耐世特(01316.HK)中期收入21億美元 同比增加17.4%
格隆匯8月16日丨耐世特(01316.HK)公佈,公司於2023年前6個月取得創紀錄的收入21億美元,較2022年同期增加310.7百萬美元或17.4%。收入增長主要受過去數年大量新及新獲取項目投產以及行業產量增加所推動。所有分部的收入均實現同比增長,其中亞太地區的增幅最大,達43.7%。
2023年首六個月經調整EBITDA為186.1百萬美元,與2022年同期相比增加28.0百萬美元或17.7%。盈利能力提高是由收入增加帶來的利潤影響所推動,但部分被通脹壓力造成的成本上升及外匯匯兑所抵銷。公司權益持有人應占集團淨利潤為34.0百萬美元或佔總收入的1.6%,較截至2022年6月30日止六個月的虧損11.1百萬美元增加45.1百萬美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.